The global Palbociclib Market is poised for substantial growth in the coming years, driven by increasing demand for advanced cancer therapies and the rising prevalence of breast cancer worldwide. According to a recent report by Dataintelo, the market is projected to grow at a CAGR of 6.8% from 2023 to 2030, reaching a valuation of USD 6.5 billion by 2030. This growth is...